None
Quote | INmune Bio Inc. (NYSE:INMB)
Last: | $ |
---|---|
Change Percent: | 3.27% |
Open: | $5.00 |
Close: | $5.05 |
High: | $5.30 |
Low: | $4.8001 |
Volume: | 22,030 |
Last Trade Date Time: | 02/12/2020 04:40:27 pm |
News | INmune Bio Inc. (NYSE:INMB)
Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced today t...
Boca Raton, Florida, April 23, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is delighted to announce the suc...
Message Board Posts | INmune Bio Inc. (NYSE:INMB)
Subject | By | Source | When |
---|---|---|---|
Did the trial in ovarian ever start? | jondoeuk | investorshub | 04/11/2023 7:45:58 PM |
Don't need to convince us. We are fully | derkampfer | investorshub | 04/09/2023 1:10:54 PM |
Sure, it is early days in patients, but | jondoeuk | investorshub | 04/06/2023 11:10:04 PM |
blocked | dennisdave | investorshub | 12/01/2022 3:05:20 PM |
INMB chart....finally a reversal? | conix | investorshub | 03/30/2022 1:11:42 AM |
News, Short Squeeze, Breakout and More Instantly...
Boca Raton, Florida, April 25, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced today t...
Boca Raton, Florida, April 23, 2024 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, is delighted to announce the suc...
2024-04-22 11:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...